Dynacor Gold Mines stock forecast
Dynacor Gold Mines (OA5) Stock Forecast & Price Target
OA5 Analyst Ratings
OA5 Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Atrium Research | €6.04 | buy | 78.32%Upside | Reiterated | 07/09/26 | |||
| Yuri Lynk | Canaccord Genuity | €5.41 | buy | 59.55%Upside | Reiterated | 04/10/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| BuyReiterated€6.04 | 07/09/26 | 78.32%Upside | |||
| Yuri LynkCanaccord Genuity | BuyReiterated€5.41 | 04/10/26 | 59.55%Upside |
Best Analysts Covering Dynacor Gold Mines
Copying Yuri Lynk's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of -0.60% per trade.
Copying Yuri Lynk's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.40% per trade.
Copying Yuri Lynk's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +1.35% per trade.
OA5 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, OA5 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. OA5 average Analyst price target in the past 3 months is ―.
OA5 Financial Forecast
OA5 Earnings Forecast
Next quarter’s earnings estimate for OA5 is EUR 0.11 with a range of EUR 0.11 to EUR 0.11. The previous quarter’s EPS was EUR 0.06. Its overall industry beat the EPS estimate 45.00% of the time in the past 12 months.
OA5 Sales Forecast
Next quarter’s sales forecast for OA5 is EUR 131.54M with a range of EUR 120.38M to EUR 142.71M. The previous quarter’s sales results were EUR 132.44M. Its overall industry beat sales estimates 58.40% of the time in the past 12 months.

